Actinium Pharmaceuticals
ATNM
#9344
Rank
S$61.7 M
Marketcap
$1.98
Share price
5.76%
Change (1 day)
-65.69%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -S$63.06 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are S$0.08 Million. In 2023 the company made an earning of -S$69.86 Million a decrease over its 2022 earnings that were of -S$45.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$63.06 Million-9.74%
2023 -S$69.86 Million52.24%
2022 -S$45.89 Million36.61%
2021 -S$33.59 Million11.48%
2020 -S$30.14 Million1.46%
2019 -S$29.7 Million-7.37%
2018 -S$32.07 Million-11.46%
2017 -S$36.21 Million10.67%
2016 -S$32.72 Million15.7%
2015 -S$28.28 Million-14.86%
2014 -S$33.22 Million129.19%
2013 -S$14.5 Million-8.55%
2012 -S$15.85 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$50.05 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.52 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.14 Billion 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA